PubPeer
The online Journal club
login
create account
Home
Publications
Effectiveness of Tocilizumab, Sarilumab, and Anakinra for critically ill patients with COVID-19 The REMAP-CAP COVID-19 Immune Modulation Therapy Domain Randomized Clinical Trial
bioRxiv (2021) -
Comments
doi: 10.1101/2021.06.18.21259133
Lennie P.G. Derde
Go to article
Go to preprint
Comments awaiting moderation ({{totalComments}})
Review last reports ({{totalReports}})
Review last email suggestions ({{totalPendingEmails}})
Last month's whitelisted comments ({{totalWhitelistedComments}})